Stockreport

NewLink's indoximod shows positive action in early-stage study in aggressive type of brain tumor; shares up 3% [Seeking Alpha]

NEWLINK GENETICS  (NLNK) 
Last newlink genetics earnings: 2/28 09:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.linkp.com/investor-relations
PDF NewLink Genetics ( NLNK ) is up on below-average volume on its announcement of updated data from a Phase 1 clinical trial assessing indoximod + front-line rad [Read more]